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The number of cancer survivors is expected to grow to 19 million by January 2024, contributed by 3 advances in detection and treatment as well as an aging population (1). About 40% of new breast 4 cancer diagnoses occur in those ≥65 years old, and these patients comprise the majority of breast 5 cancer deaths and current breast cancer survivors (2). Among the challenges of caring for older 6 patients with cancer is appropriately balancing treatment outcomes, such as survival, with health-7 related quality of life (HRQoL) (3). There is growing evidence that HRQoL in cancer patients of all 8 ages is not only an important outcome in itself but also a predictor of mortality (4-7).
10
Motivation plays an important role in an older patient's ability to overcome illness and stay engaged optimism and hope, have been linked to both disease-specific and all-cause mortality (9-11).
19
However, GOB's ability to predict mortality, either independently or in association with HRQoL, has 20 yet to be studied.
22
In this secondary analysis of the same cohort of older women with early stage breast cancer studied 23 by Clough-Gorr et al., we assessed the association between GOB and 5-and 10-year mortality, both 24 all-cause and breast cancer-specific (BC-specific). We hypothesized that higher GOB scores would 25 be associated with lower all-cause and BC-specific mortality. Moreover, we hypothesized that GOB 
29
Knowledge of HRQoL will therefore allow an investigation into whether GOB has an independent 30 effect on mortality (12).
32 33

Materials and Methods
35
Study Population
37
The longitudinal study design and subject recruitment procedures have been reported previously (13).
38
In brief, 660 women ≥65-years old with stage I tumor diameter ≥1cm or stage II-IIIA disease and 39 permission from attending physicians to be contacted in four geographic regions (Los Angeles, 40 California; Minnesota; North Carolina; Rhode Island) were identified through regular pathology report 41 review at hospitals or collaborating tumor registries. Women could not have a prior primary breast 42 cancer or simultaneously diagnosed or treated second primary tumor. Data were collected by medical 43 record review (definitive surgery date, surgery type, tumor characteristics) and telephone interviews 44 (socio-demographic, HRQoL variables, breast cancer therapy) beginning at least three-months after 45 surgery and continuing annually for 10 years. Causes of death -characterized as breast cancer-46 specific, all-cause, all-cancer-related -were collected through 10 years of follow-up.
48
Mortality, all-cause and breast cancer-specific 49 50 Decedents were identified by first and last name, middle initial, Social Security number, date of birth 51 (DOB), sex, race, marital status, and state of residence matched against National Death Index (NDI) 52 and Social Security Death Index (SSDI) records (14) . Survival status at the end of 2007 was complete 53 for all women.
55
Socio-demographic characteristics 56 We classified patient age as 65-69, 70-79, ≥80-years; race as white, other; education as <12-years, 57 12-years, >12-years; and marital status as married (yes/no).
59
Breast cancer characteristics 60 61 We categorized stage as I-III using the TNM classification (15). Definitive primary therapy was 62 mastectomy plus axillary lymph node dissection (ALND) or breast-conserving surgery (BCS) plus 63 ALND.
65
Getting out of Bed 66 67 GOB (Table 1) consists of four items scored on an ordinal scale of 1 to 5. The language used in 68 these items was intended to be straightforward using concepts and terms universally understood at a 69 layperson's level of understanding. GOB total score is calculated as an equally weighted sum of items 70 (1=poor, 2=fair, 3=good, 4=very good, 5=excellent) giving a total score range from 4 to 20. The final 71 score is transformed to 0-100, with a higher score indicating greater motivation (8).
73
Health-related quality of life characteristics 74 75 To further evaluate an independent association between GOB and mortality, we studied other HRQoL has been linked to mortality in older patients with cancer (7, 16). Moreover, physical function has 79 been shown to be associated with other measures similar to motivation (8, (17) (18) (19) . We calculated 80 physical function using the 10-item Physical Function Index (PFI-10) from the Medical Outcomes
81
Study Short Form-36 (MOS SF-36) (20). PFI-10 specifically has previously been linked to mortality in 82 men and women (21, 22) . Mental health has also been linked to survival in both older and younger 83 cancer patients (23, 24) . Furthermore, mental health has been shown to be associated with GOB and 84 other measures similar to motivation (8, (25) (26) (27) . General mental health was assessed by the Mental
85
Health Index (MHI-5), a five-item measure of mental health from the MOS- . specifically has been linked to mortality in cancer patients and in other populations (14, 28, 29) .
88
Emotional health, psychosocial function, and social support have all been associated with measures 89 similar to motivation (8, 30, 31) . Breast cancer-specific emotional health (BCSEH) was assessed 90 using a four-item measure reflecting how well the respondent was dealing with breast cancer-specific 91 worries (32). We used the Psychosocial Summary Scale of the 17-item Cancer Rehabilitation
92
Evaluation System-Short Form (CARES-SF) to capture cancer-specific psychosocial function (33).
93
The CARES-SF item scores range from 1 to 4 (a higher score indicating more problems). Social 94 support is related to survival in patients with breast and other cancers (34, 35 the hazard of dying using Cox regression models from all-cause mortality and BC-specific mortality.
119
We did the same to assess the association between GOB and all-cancer mortality. We report hazard 
132
Approval of the study was obtained from each institutional review board associated with the four 133 geographic regions from which the study participants were identified and consented.
135
Results
137
Study population 138 139
Socio-demographic, breast cancer, and HRQoL characteristics of the baseline study population are 140 shown in Table 2 . The majority of women were ≥ 70 years (74.0%), white (93.9%), and had at least and of these, 72 (31.3%) were due to breast cancer, with 5179 persons-years of observation. The 10-155 year all-cause mortality rate was 4.4%, 95%CI (3.9% -5.1%), and the 10-year BC-specific mortality 156 rate was 1.4% 95%CI (1.1% -1.8%). In a cohort of older women with early stage breast cancer we determined whether a measure of 186 motivation, the 4-item GOB scale, was associated with mortality over 10 years of follow-up. We found 187 that women with better motivation had a lower hazard of all-cause mortality in unadjusted analysis.
158
188
This effect diminished after adjusting for confounding variables age, stage of breast cancer, and other
189
HRQoL measures. We found no association between motivation and BC-specific mortality at 5 years 190 and 10 years. The similar hazard ratios found by our sensitivity analysis using GOB as a continuous 191 variable suggest that selecting a different cutoff other than 80 would not have changed the results.
192
Our findings extend the goals of the original GOB validation study, which highlighted the need to 193 further test GOB's predictive ability over longer periods of time (8). Our results partially support our 194 hypothesis in that GOB would be related to mortality, however they do not support our hypothesis that 
198
Previous studies have measured concepts similar to motivation such as hope and optimism and 199 found them to be related to health outcomes in a variety of patient populations. However the evidence 200 is equivocal that these concepts are independently associated with mortality in cancer patients 45). In support of an independent association, "dispositional optimism" was found to predict one-year 202 survival in patients with head and neck cancer (46), "pessimism" was linked to lower survival in lung 203 cancer patients (47), and a hope for the curability of cancer correlated with higher survival in 204 nonmetastatic colon cancer patients (48). Other studies do not support an independent association 205 between measures similar to motivation and mortality: in over 90,000 women from the Women's
206
Health Initiative who were at baseline free of cardiovascular disease and cancer, optimism measured 207 using the Life Orientation Test-Revised was found to be independently associated with a lower 208 hazard of coronary heart disease and coronary heart disease-related mortality in all patients, but was 209 found only in black patients to be independently associated with cancer-related mortality (49 respectively (24). The authors found that baseline hopefulness was associated with overall survival in 216 unadjusted analysis, whereas optimism was not. Similar to our study, the association between 217 hopefulness and survival weakened after adjusting for known prognostic variables. Our results
218
suggest that much of the decrease in mortality in women with baseline GOB ≥ 80 vs. women with 219 GOB < 80 was because women with GOB≥ 80 were younger and/or had less advanced disease, not 220 because they had higher levels of motivation per se. Moreover, younger patients are more likely to 221 have fewer comorbidities and receive guideline-recommended therapy -two factors not included in 222 our analysis that might also contribute to lower mortality (52-57).
224
Our study shows that the relation between GOB and mortality is confounded not only by age and 225 cancer stage, but also by the HRQoL variables included in our study (Table 3) . We found weak to 226 moderate correlations among GOB, MHI-5, PFI-10, BCSEH, CARES-SF, and mMOS-SS (Table 4) , 227 complementing the original GOB study that found associations between GOB and MHI-5 as well as hope and mortality weakened (24). Likewise, our results suggest that even after adjusting for age and 236 stage, much of the remaining decrease in mortality in women with baseline GOB ≥ 80 was because 237 these women had higher scores of mental health and physical functioning, not a higher score of 238 motivation.
240
Strengths of our study include the long follow-up period, tracking mortality in participants for 10 years.
241
Further, survival status was complete through 10 years, thus avoiding selection bias due to lost to 242 follow-up. Limitations include a population that was largely white, well-educated, and from four 243 specific regions in the US, limiting the generalizability of our findings. Whereas we found that GOB
244
was not independently associated with breast cancer-specific or all-cause mortality, we did not test variance trade-off. Thus, point estimates from adjusted models in our data might vary across different 254 models due to wide confidence intervals rather than reflecting the true population values.
256
In conclusion, our results suggest that a previously validated measure of motivation, GOB, is * GOB affects mortality and is associated with HRQoL, which also affects mortality. Therefore, any observed effect GOB may have on mortality might in fact be due to its association with HRQoL (12). This confounding situation can be solved by adjusting for HRQoL, such that GOB is an independent predictor for mortality. 
